Skip to main content
. 2025 Jan 24;5:23. [Version 1] doi: 10.12688/openreseurope.19077.1

Table 5. Inclusion and exclusion criteria for the STROGHAT clinical trial.

Inclusion criteria Exclusion criteria
1 Able to give signed informed consent (assent
for adolescents)
Individuals with a positive parasitological exam on the
spot at baseline
2 Both sexes Participants previously treated for g-HAT or previously
treated because of gHAT seropositive results
3 11 years of age or older and weight ≥30 kg Pregnant women
4 CATT or RDT test positive Breast-feeding women
5 Able to ingest oral tablets Children ≥11 years but under 30kg body weight
6 Known address and/or contact details provided Clinically significant medical condition
7 Able to comply with the schedule of follow-up
visits and other study requirements
Jaundice
8 Agree not to take part in any other clinical trials
during the participation in the clinical trial
Participants who are taking, or who are expected to need
to start within 4 months, a medicine (including traditional
or herbal) which may interact with acoziborole and which
cannot be stopped or adjusted

Only individuals complying with all the inclusion criteria can participate in the STROGHAT nested clinical trial. Presence of one of the exclusion criteria excludes participation in the study.